
Marcela M. Cordero Garcia
Examiner (ID: 4537)
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1676, 1658 |
| Total Applications | 1421 |
| Issued Applications | 950 |
| Pending Applications | 83 |
| Abandoned Applications | 394 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9546720
[patent_doc_number] => 20140171369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-19
[patent_title] => 'Pharmaceutical Composition'
[patent_app_type] => utility
[patent_app_number] => 14/111072
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11479
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111072
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/111072 | Pharmaceutical composition | Apr 12, 2012 | Issued |
Array
(
[id] => 8660064
[patent_doc_number] => 20130040893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'TREATMENT OF PROLIFERATIVE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/446638
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9656
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13446638
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/446638 | TREATMENT OF PROLIFERATIVE DISORDERS | Apr 12, 2012 | Abandoned |
Array
(
[id] => 9318753
[patent_doc_number] => 20140051092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'Method And Apparatus For The Analysis Of Biological Samples'
[patent_app_type] => utility
[patent_app_number] => 14/110258
[patent_app_country] => US
[patent_app_date] => 2012-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3646
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110258
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110258 | Method And Apparatus For The Analysis Of Biological Samples | Apr 11, 2012 | Abandoned |
Array
(
[id] => 10020673
[patent_doc_number] => 09063149
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-23
[patent_title] => 'Quantitative standard for mass spectrometry of proteins'
[patent_app_type] => utility
[patent_app_number] => 14/009801
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 12
[patent_no_of_words] => 31716
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14009801
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/009801 | Quantitative standard for mass spectrometry of proteins | Apr 3, 2012 | Issued |
Array
(
[id] => 10547414
[patent_doc_number] => 09272014
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Galectin-3C combination therapy for human cancer'
[patent_app_type] => utility
[patent_app_number] => 14/008262
[patent_app_country] => US
[patent_app_date] => 2012-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 26
[patent_no_of_words] => 14864
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008262
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/008262 | Galectin-3C combination therapy for human cancer | Mar 28, 2012 | Issued |
Array
(
[id] => 8417584
[patent_doc_number] => 20120245084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'FORMULATIONS OF DILUTED AMINO ACID SEGMENTS AND METHODS FOR MAKING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/428907
[patent_app_country] => US
[patent_app_date] => 2012-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14279
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13428907
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/428907 | Formulations of diluted amino acid segments and methods for making same | Mar 22, 2012 | Issued |
Array
(
[id] => 9140463
[patent_doc_number] => 08580923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-12
[patent_title] => 'Self-assembling peptide amphiphiles and related methods for growth factor delivery'
[patent_app_type] => utility
[patent_app_number] => 13/423310
[patent_app_country] => US
[patent_app_date] => 2012-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 12819
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13423310
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/423310 | Self-assembling peptide amphiphiles and related methods for growth factor delivery | Mar 18, 2012 | Issued |
Array
(
[id] => 11356312
[patent_doc_number] => 09532950
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Vector for pulmonary delivery, inducing agent, and uses'
[patent_app_type] => utility
[patent_app_number] => 14/004942
[patent_app_country] => US
[patent_app_date] => 2012-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 21
[patent_no_of_words] => 15161
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004942
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/004942 | Vector for pulmonary delivery, inducing agent, and uses | Mar 12, 2012 | Issued |
Array
(
[id] => 8266072
[patent_doc_number] => 20120165504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'VANCOMYCIN B HYDROCHLORIDE CRYSTALLINE FORM 1'
[patent_app_type] => utility
[patent_app_number] => 13/412886
[patent_app_country] => US
[patent_app_date] => 2012-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2588
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13412886
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/412886 | VANCOMYCIN B HYDROCHLORIDE CRYSTALLINE FORM 1 | Mar 5, 2012 | Abandoned |
Array
(
[id] => 9026540
[patent_doc_number] => 08536122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-17
[patent_title] => 'Acylated GLP-1 compounds'
[patent_app_type] => utility
[patent_app_number] => 13/412283
[patent_app_country] => US
[patent_app_date] => 2012-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19214
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13412283
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/412283 | Acylated GLP-1 compounds | Mar 4, 2012 | Issued |
Array
(
[id] => 8370212
[patent_doc_number] => 20120219603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'Use of Calcitonin for the Treatment of RA'
[patent_app_type] => utility
[patent_app_number] => 13/410100
[patent_app_country] => US
[patent_app_date] => 2012-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10384
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13410100
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/410100 | Use of Calcitonin for the Treatment of RA | Feb 29, 2012 | Abandoned |
Array
(
[id] => 8611838
[patent_doc_number] => 20130017150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY'
[patent_app_type] => utility
[patent_app_number] => 13/402620
[patent_app_country] => US
[patent_app_date] => 2012-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 26086
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13402620
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/402620 | Methods for prevention and treatment of acute renal injury | Feb 21, 2012 | Issued |
Array
(
[id] => 8406665
[patent_doc_number] => 20120238731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-20
[patent_title] => 'METHODS OF PREPARATION OF CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 13/397205
[patent_app_country] => US
[patent_app_date] => 2012-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 51353
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13397205
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/397205 | Methods of preparation of conjugates | Feb 14, 2012 | Issued |
Array
(
[id] => 8346825
[patent_doc_number] => 20120207748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'T-140 PEPTIDE ANALOGS HAVING CXCR4 SUPER-AGONIST ACTIVITY FOR CANCER THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/360751
[patent_app_country] => US
[patent_app_date] => 2012-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 18728
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13360751
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/360751 | T-140 peptide analogs having CXCR4 super-agonist activity for cancer therapy | Jan 28, 2012 | Issued |
Array
(
[id] => 10567379
[patent_doc_number] => 09290537
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-22
[patent_title] => 'Method for cross-linking peptides'
[patent_app_type] => utility
[patent_app_number] => 13/996583
[patent_app_country] => US
[patent_app_date] => 2011-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 26
[patent_no_of_words] => 17371
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996583
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/996583 | Method for cross-linking peptides | Dec 22, 2011 | Issued |
Array
(
[id] => 9597166
[patent_doc_number] => 20140193846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'NOVEL APOC-I ISOFORMS AND THEIR USE AS BIOMARKERS AND RISK FACTORS OF ATHEROSCLEROTIC DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/112670
[patent_app_country] => US
[patent_app_date] => 2011-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 27183
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112670
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112670 | NOVEL APOC-I ISOFORMS AND THEIR USE AS BIOMARKERS AND RISK FACTORS OF ATHEROSCLEROTIC DISEASE | Dec 22, 2011 | Abandoned |
Array
(
[id] => 8713275
[patent_doc_number] => 08399415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-19
[patent_title] => 'Oligopeptides and cosmetic compositions containing the oligopeptides'
[patent_app_type] => utility
[patent_app_number] => 13/328684
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9725
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13328684
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/328684 | Oligopeptides and cosmetic compositions containing the oligopeptides | Dec 15, 2011 | Issued |
Array
(
[id] => 9191004
[patent_doc_number] => 20130330319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'CELL MIGRATION MODULATOR'
[patent_app_type] => utility
[patent_app_number] => 13/993511
[patent_app_country] => US
[patent_app_date] => 2011-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10213
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993511
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/993511 | Cell migration regulator | Dec 11, 2011 | Issued |
Array
(
[id] => 8221714
[patent_doc_number] => 20120135920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'Preparation Comprising Insulin, Nicotinamide and an Amino Acid'
[patent_app_type] => utility
[patent_app_number] => 13/309134
[patent_app_country] => US
[patent_app_date] => 2011-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11332
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13309134
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/309134 | Preparation comprising insulin, nicotinamide and an amino acid | Nov 30, 2011 | Issued |
Array
(
[id] => 7804829
[patent_doc_number] => 20120055781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'MICROWAVE-ASSISTED PEPTIDE SYNTHESIS'
[patent_app_type] => utility
[patent_app_number] => 13/294478
[patent_app_country] => US
[patent_app_date] => 2011-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8767
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20120055781.pdf
[firstpage_image] =>[orig_patent_app_number] => 13294478
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/294478 | Microwave-assisted peptide synthesis | Nov 10, 2011 | Issued |